Saw that Braidwell fund just dumped nearly 1.8 million Xenon shares - that's like $75 million worth gone in Q4. Stock's sitting around $42 now and honestly the timing is interesting because they're waiting on Phase 3 data for their seizure drug that's supposed to drop in March. So basically they're trimming before the binary event. Smart move honestly.

What caught my eye is how they sized it though. Xenon went from being a bigger position down to 2.6% of their portfolio. Still meaningful but not like, all-in. Feels like they're saying 'yeah we like the pipeline but we're not betting the farm on one data readout.' The company's got five other Phase 3 studies running plus longer-term data showing seizure reductions, so it's not like they're abandoning ship.

Stock's only up 6% over the past year which is pretty meh for biotech. Lot of volatility in there too. I get why a fund would want to take some chips off the table and spread that capital around. Biotech is all about hitting milestones and Xenon's got a real one coming. If the data's good it could pop, if not... yeah that's why diversification matters. Just interesting watching the smart money position ahead of catalyst events like this.